A while back, I told you about a controversy that had been brewing in the dermatological world: Several cosmetic companies -- after discovering that glaucoma drugs that include ingredients known as prostaglandins had the surprising side effect of creating thicker, longer eyelashes -- began including prostaglandin-like ingredients in cosmetic products. Trouble is, the FDA had not verified or approved the assertion that such ingredients lengthen lashes, which forced cosmetics companies to retract the claim and reformulate their products.
Well, I'm pleased to share the latest update on this topic: On December 26, 2008, the drug company Allergan announced that the FDA had approved Latisse 0.03% as a treatment for hypotrichosis (the medical term for sparse eyelashes. The active ingredient in Latisse, bimatoprost, was approved for the treatment of eye disorders like glaucoma years ago, but this is the first time it has been officially approved to enhance the eyelashes (defined here as an increase in length, thickness, and darkness).
2 comments:
i appreciate this news..tnx, how about for eyebrows? do you know meds for eyebrows to grow?
eh,wer can we buy this latisse? is it available in drug stores? an how much? is it otc drug?
Post a Comment